Kathryn A Bryant, NP
Nurse Practitioner · Petaluma
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 12 years
- University of Nevada School of Medicine, 2014
Offices
4 locations · Providence Medical Foundation · 1,461 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center · Petaluma Valley Hospital · Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kathryn A Bryant’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$95,550
Medicare paid this office $95,550 for 265 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 178 | $28,818 | $77 |
| Injection, denosumab, 1 mg | 19 | $28,358 | None |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 109 | $13,071 | $120 |
| Short return visit (20+ min) | 72 | $4,875 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $3,130 | $55 |
See all 10 services
| Return visit (30+ min) | 178 | $28,818 | $77 |
| Injection, denosumab, 1 mg | 19 | $28,358 | None |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 109 | $13,071 | $120 |
| Short return visit (20+ min) | 72 | $4,875 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $3,130 | $55 |
| Influenza vaccine, inactivated | 20 | $1,636 | $82 |
| Administration of influenza virus vaccine | 25 | $879 | $35 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $506 | $32 |
| Injection of drug or substance under skin or into muscle | 20 | $281 | $11 |
| Automated urinalysis test | 14 | $33 | $2 |
Who their Medicare patients are
265 Original Medicare patients in 2024. Average age 76 · Women 63% · Also on Medicaid 5% · Health risk score 1.03. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 68% · Coronary heart disease 24% · Depression 20% · Diabetes 19% · Chronic kidney disease 18% · Atrial fibrillation 16% · Heart failure 15% · Cancer 15% · COPD 10% · Stroke 6%.
The office billed $422,153, Medicare allowed $125,172 and paid $95,550; for 2,874 services of 33 kinds; $38,040 of it was for drugs given in the office and $57,510 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 265 | 2,874 | 76 | 1.03 | $422,153 | $95,550 |
| 2023 | 259 | 4,036 | 76 | 0.95 | $329,394 | $115,698 |
| 2022 | 293 | 4,138 | 76 | 1.03 | $271,675 | $95,119 |
| 2021 | 216 | 1,087 | 76 | 1.03 | $99,207 | $47,269 |
| 2020 | 169 | 613 | 74 | 0.99 | $78,296 | $32,650 |
| 2019 | 179 | 573 | 73 | 1.08 | $68,147 | $27,354 |
| 2018 | 164 | 355 | 75 | 1.07 | $43,579 | $15,954 |
| 2017 | 172 | 404 | 73 | 0.99 | $47,681 | $17,647 |
| 2016 | 256 | 442 | 72 | 0.99 | $79,820 | $23,237 |
| 2015 | 140 | 762 | 68 | 1.04 | $89,946 | $27,289 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Injection, denosumab, 1 mg | 31 | $46,317 | None |
| Return visit (30+ min) | 172 | $31,860 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 104 | $12,410 | $119 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 20 | $5,638 | $282 |
| Short return visit (20+ min) | 77 | $5,196 | $55 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 29 | $2,198 | $76 |
| Administration of influenza virus vaccine | 35 | $1,022 | $28 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $998 | $67 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $713 | $42 |
| Administration of pneumococcal vaccine | 22 | $624 | $28 |
| Injection of drug or substance under skin or into muscle | 37 | $500 | $11 |
| Hemoglobin a1c level | 15 | $152 | $10 |
| Automated urinalysis test | 14 | $40 | $2 |
2022: 10 services
| Injection, denosumab, 1 mg | 30 | $33,910 | None |
| Return visit (30+ min) | 165 | $21,508 | $85 |
| Short return visit (20+ min) | 115 | $8,867 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $7,175 | $124 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,449 | $278 |
| Pneumococcal vaccine, 23-valent | 14 | $1,859 | $133 |
| Influenza vaccine split virus, preservative free | 16 | $1,019 | $64 |
| Administration of pneumococcal vaccine | 29 | $833 | $29 |
| Administration of influenza virus vaccine | 19 | $542 | $29 |
| Injection of drug or substance under skin or into muscle | 35 | $495 | $11 |
2021: 8 services
| Return visit (30+ min) | 117 | $16,833 | $81 |
| Short return visit (20+ min) | 95 | $8,699 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $8,109 | $125 |
| Influenza vaccine split virus, preservative free | 24 | $1,553 | $65 |
| Pneumococcal vaccine, 23-valent | 11 | $1,379 | $125 |
| Administration of influenza virus vaccine | 24 | $396 | $17 |
| Administration of pneumococcal vaccine | 13 | $214 | $16 |
| Urinalysis, manual test | 17 | $70 | $3 |
2020: 7 services
| Return visit (30+ min) | 97 | $10,959 | $67 |
| Short return visit (20+ min) | 98 | $7,219 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,166 | $109 |
| Influenza vaccine split virus, preservative free | 41 | $2,555 | $61 |
| Pneumococcal vaccine, 23-valent | 20 | $2,350 | $118 |
| Administration of influenza virus vaccine | 42 | $760 | $18 |
| Administration of pneumococcal vaccine | 30 | $528 | $18 |
2019: 8 services
| Return visit (30+ min) | 97 | $8,847 | $63 |
| Short return visit (20+ min) | 106 | $7,050 | $45 |
| Pneumococcal vaccine, 13-valent | 12 | $2,502 | $209 |
| Influenza vaccine split virus, preservative free | 42 | $2,300 | $55 |
| Pneumococcal vaccine, 23-valent | 18 | $1,989 | $111 |
| Administration of influenza virus vaccine | 47 | $815 | $17 |
| Administration of pneumococcal vaccine | 29 | $503 | $17 |
| Urinalysis, manual test | 17 | $75 | $3 |
2018: 5 services
| Return visit (30+ min) | 76 | $5,874 | $58 |
| Short return visit (20+ min) | 108 | $5,357 | $39 |
| Influenza vaccine split virus, preservative free | 28 | $1,452 | $52 |
| Administration of influenza virus vaccine | 29 | $623 | $21 |
| Urinalysis, manual test | 11 | $44 | $3 |
2017: 4 services
| Short return visit (20+ min) | 124 | $7,497 | $39 |
| Return visit (30+ min) | 60 | $6,214 | $69 |
| Short return visit | 24 | $340 | $13 |
| Urinalysis, manual test | 16 | $75 | $3 |
2016: 4 services
| Return visit (30+ min) | 150 | $14,106 | $56 |
| Short return visit (20+ min) | 103 | $4,837 | $42 |
| New patient visit (45+ min) | 20 | $1,909 | $95 |
| Short return visit | 16 | $487 | $29 |
2015: 4 services
| Return visit (30+ min) | 124 | $21,576 | $65 |
| Short return visit (20+ min) | 31 | $1,303 | $39 |
| Administration of influenza virus vaccine | 20 | $520 | $26 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 14 | $165 | $12 |
Drugs they prescribed that Part D paid
$386,824
Pharmacies billed $386,824 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (116 of 3,175) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
2,738 generic and 415 brand-name prescriptions · $386,824 in drug cost · 94 antibiotic prescriptions to 69 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 40 | $47,751 | $1,194 |
| Jardiance | 24 | $41,577 | $1,732 |
| Januvia | 25 | $37,464 | $1,499 |
| Eliquis | 36 | $35,225 | $978 |
| Trelegy Ellipta | 17 | $21,745 | $1,279 |
See all 77 drugs
| Ozempic | 40 | $47,751 | $1,194 |
| Jardiance | 24 | $41,577 | $1,732 |
| Januvia | 25 | $37,464 | $1,499 |
| Eliquis | 36 | $35,225 | $978 |
| Trelegy Ellipta | 17 | $21,745 | $1,279 |
| Trulicity | 15 | $16,121 | $1,075 |
| Repatha Sureclick | 13 | $14,379 | $1,106 |
| Wixela Inhub | 13 | $2,700 | $208 |
| Sertraline | 66 | $2,372 | $36 |
| Levothyroxine | 171 | $2,244 | $13 |
| Gabapentin | 68 | $2,088 | $31 |
| Atorvastatin | 196 | $1,854 | $9 |
| Lantus Solostar | 15 | $1,422 | $95 |
| Synthroid | 17 | $1,315 | $77 |
| Tamsulosin | 66 | $1,259 | $19 |
| Simvastatin | 129 | $1,183 | $9 |
| Zolpidem Tartrate Er | 12 | $1,153 | $96 |
| Omeprazole | 55 | $1,012 | $18 |
| Fluticasone-Salmeterol | 11 | $927 | $84 |
| Oxycodone-Acetaminophen | 43 | $910 | $21 |
| Lisinopril | 115 | $790 | $7 |
| Albuterol Sulfate Hfa | 31 | $785 | $25 |
| Duloxetine | 32 | $739 | $23 |
| Bupropion Xl | 14 | $727 | $52 |
| Amlodipine Besylate | 106 | $723 | $7 |
| Losartan | 71 | $647 | $9 |
| Levetiracetam | 11 | $611 | $56 |
| Ezetimibe | 18 | $581 | $32 |
| Hydrocodone-Acetaminophen | 35 | $580 | $17 |
| Pregabalin | 27 | $577 | $21 |
| Metoprolol | 43 | $550 | $13 |
| Escitalopram | 24 | $532 | $22 |
| Zolpidem | 62 | $508 | $8 |
| Nifedipine Er | 12 | $476 | $40 |
| Lorazepam | 41 | $428 | $10 |
| Clopidogrel | 18 | $411 | $23 |
| Metformin | 34 | $410 | $12 |
| Fluticasone Propionate | 13 | $403 | $31 |
| Famotidine | 29 | $399 | $14 |
| Pantoprazole | 32 | $387 | $12 |
| Cyclobenzaprine | 31 | $382 | $12 |
| Rosuvastatin | 22 | $353 | $16 |
| Finasteride | 20 | $348 | $17 |
| Carvedilol | 20 | $345 | $17 |
| Fluoxetine | 28 | $322 | $11 |
| Trazodone | 56 | $316 | $6 |
| Metformin Hcl Er | 41 | $298 | $7 |
| Liothyronine | 12 | $276 | $23 |
| Allopurinol | 42 | $272 | $6 |
| Pravastatin | 15 | $270 | $18 |
| Potassium Chloride | 14 | $266 | $19 |
| Methylphenidate | 12 | $228 | $19 |
| Alprazolam | 36 | $214 | $6 |
| Alendronate | 16 | $204 | $13 |
| Celecoxib | 12 | $197 | $16 |
| Warfarin | 17 | $186 | $11 |
| Dextroamphetamine-Amphetamine | 11 | $169 | $15 |
| Clonazepam | 44 | $159 | $4 |
| Benazepril | 18 | $157 | $9 |
| Hydrochlorothiazide | 25 | $152 | $6 |
| Latanoprost | 12 | $140 | $12 |
| Triamterene-Hydrochlorothiazid | 16 | $137 | $9 |
| Tramadol | 32 | $128 | $4 |
| Furosemide | 15 | $120 | $8 |
| Terazosin | 12 | $113 | $9 |
| Lisinopril-Hydrochlorothiazide | 17 | $108 | $6 |
| Meloxicam | 20 | $98 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $96 | $8 |
| Eszopiclone | 15 | $92 | $6 |
| Cephalexin | 24 | $81 | $3 |
| Amoxicillin-Clavulanate Potass | 12 | $70 | $6 |
| Ciprofloxacin | 19 | $68 | $4 |
| Ibuprofen | 15 | $65 | $4 |
| Metoprolol | 18 | $61 | $3 |
| Azithromycin | 14 | $56 | $4 |
| Estradiol | 11 | $24 | $2 |
| Prednisone | 13 | $22 | $2 |
Year by year
| 2024 | 3,175 | 340 | 4% (116) | 13% | $386,824 |
| 2023 | 2,732 | 311 | 5% (133) | 11% | $364,520 |
| 2022 | 2,278 | 359 | 5% (116) | 12% | $289,421 |
| 2021 | 1,732 | 212 | 5% (81) | 13% | $168,873 |
| 2020 | 1,552 | 213 | 4% (61) | 13% | $105,371 |
| 2019 | 1,367 | 219 | 4% (49) | 9% | $68,058 |
| 2018 | 1,043 | 174 | 6% (59) | None | $56,244 |
| 2017 | 832 | 225 | 2% (20) | None | $39,906 |
| 2016 | 3,286 | 286 | 5% (173) | 16% | $157,132 |
| 2015 | 2,760 | 212 | 6% (174) | None | $128,744 |
| 2014 | 80 | 25 | None | 16% | $3,046 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 63 drugs
| Januvia | 39 | $56,796 | $1,456 |
| Jardiance | 26 | $43,236 | $1,663 |
| Ozempic | 20 | $34,308 | $1,715 |
| Creon | 11 | $33,715 | $3,065 |
| Eliquis | 17 | $21,058 | $1,239 |
| Advair Diskus | 14 | $5,417 | $387 |
| Lantus Solostar | 11 | $5,325 | $484 |
| Levothyroxine | 151 | $3,367 | $22 |
| Atorvastatin | 156 | $2,780 | $18 |
| Gabapentin | 60 | $1,770 | $30 |
| Hydrocodone-Acetaminophen | 60 | $1,610 | $27 |
| Lisinopril | 117 | $1,291 | $11 |
| Methylphenidate Er | 15 | $1,240 | $83 |
| Simvastatin | 104 | $1,203 | $12 |
| Bupropion Xl | 11 | $1,075 | $98 |
| Losartan | 74 | $1,029 | $14 |
| Tamsulosin | 45 | $1,014 | $23 |
| Amlodipine Besylate | 95 | $1,003 | $11 |
| Trazodone | 40 | $892 | $22 |
| Metoprolol | 42 | $851 | $20 |
| Pregabalin | 16 | $802 | $50 |
| Albuterol Sulfate Hfa | 26 | $766 | $29 |
| Pantoprazole | 24 | $643 | $27 |
| Sertraline | 31 | $579 | $19 |
| Escitalopram | 38 | $575 | $15 |
| Metformin | 35 | $567 | $16 |
| Ezetimibe | 11 | $562 | $51 |
| Duloxetine | 24 | $514 | $21 |
| Valacyclovir | 12 | $507 | $42 |
| Zolpidem | 43 | $492 | $11 |
| Pravastatin | 26 | $474 | $18 |
| Lorazepam | 43 | $448 | $10 |
| Nifedipine Er | 12 | $430 | $36 |
| Allopurinol | 34 | $427 | $13 |
| Metformin Hcl Er | 30 | $405 | $13 |
| Famotidine | 27 | $396 | $15 |
| Eszopiclone | 16 | $381 | $24 |
| Modafinil | 11 | $380 | $35 |
| Montelukast | 11 | $352 | $32 |
| Clopidogrel | 22 | $345 | $16 |
| Rosuvastatin | 15 | $338 | $23 |
| Potassium Chloride | 16 | $329 | $21 |
| Omeprazole | 40 | $321 | $8 |
| Fluticasone Propionate | 15 | $315 | $21 |
| Benazepril | 19 | $313 | $16 |
| Triamterene-Hydrochlorothiazid | 17 | $267 | $16 |
| Clonazepam | 40 | $234 | $6 |
| Alprazolam | 32 | $223 | $7 |
| Alendronate | 14 | $202 | $14 |
| Carvedilol | 20 | $195 | $10 |
| Oxycodone-Acetaminophen | 29 | $186 | $6 |
| Methylphenidate | 11 | $184 | $17 |
| Citalopram Hbr | 12 | $179 | $15 |
| Tramadol | 34 | $172 | $5 |
| Finasteride | 16 | $166 | $10 |
| Triamcinolone Acetonide | 14 | $159 | $11 |
| Ibuprofen | 20 | $150 | $8 |
| Metoprolol | 19 | $135 | $7 |
| Hydrochlorothiazide | 34 | $118 | $3 |
| Furosemide | 17 | $109 | $6 |
| Cyclobenzaprine | 18 | $76 | $4 |
| Ciprofloxacin | 11 | $65 | $6 |
| Cephalexin | 14 | $38 | $3 |
2022: 57 drugs
| Januvia | 19 | $29,522 | $1,554 |
| Ozempic | 20 | $27,454 | $1,373 |
| Eliquis | 26 | $27,416 | $1,054 |
| Jardiance | 15 | $21,476 | $1,432 |
| Levothyroxine | 134 | $3,139 | $23 |
| Atorvastatin | 127 | $2,138 | $17 |
| Bupropion Xl | 18 | $1,898 | $105 |
| Ventolin Hfa | 14 | $1,508 | $108 |
| Methylphenidate Er | 12 | $1,444 | $120 |
| Losartan | 75 | $1,281 | $17 |
| Tamsulosin | 31 | $959 | $31 |
| Ezetimibe | 11 | $916 | $83 |
| Hydrocodone-Acetaminophen | 50 | $831 | $17 |
| Lisinopril | 80 | $816 | $10 |
| Metoprolol | 32 | $797 | $25 |
| Simvastatin | 82 | $766 | $9 |
| Finasteride | 24 | $749 | $31 |
| Albuterol Sulfate Hfa | 20 | $703 | $35 |
| Trazodone | 40 | $668 | $17 |
| Gabapentin | 33 | $659 | $20 |
| Amlodipine Besylate | 73 | $655 | $9 |
| Clopidogrel | 27 | $626 | $23 |
| Omeprazole | 29 | $611 | $21 |
| Venlafaxine Hcl Er | 11 | $508 | $46 |
| Valsartan-Hydrochlorothiazide | 14 | $493 | $35 |
| Sertraline | 35 | $442 | $13 |
| Allopurinol | 29 | $437 | $15 |
| Dextroamphetamine-Amphetamine | 12 | $436 | $36 |
| Pantoprazole | 30 | $425 | $14 |
| Baclofen | 14 | $418 | $30 |
| Carvedilol | 20 | $394 | $20 |
| Escitalopram | 17 | $311 | $18 |
| Metformin | 24 | $294 | $12 |
| Rosuvastatin | 25 | $284 | $11 |
| Famotidine | 21 | $273 | $13 |
| Alendronate | 20 | $268 | $13 |
| Alprazolam | 29 | $242 | $8 |
| Montelukast | 12 | $241 | $20 |
| Fluticasone Propionate | 14 | $234 | $17 |
| Metformin Hcl Er | 19 | $227 | $12 |
| Zolpidem | 35 | $223 | $6 |
| Citalopram Hbr | 27 | $206 | $8 |
| Triamterene-Hydrochlorothiazid | 13 | $203 | $16 |
| Tramadol | 24 | $202 | $8 |
| Ondansetron Odt | 16 | $197 | $12 |
| Lorazepam | 37 | $190 | $5 |
| Metoprolol | 20 | $179 | $9 |
| Clonazepam | 27 | $171 | $6 |
| Oxycodone-Acetaminophen | 21 | $167 | $8 |
| Benazepril | 13 | $165 | $13 |
| Furosemide | 19 | $148 | $8 |
| Ibuprofen | 11 | $139 | $13 |
| Hydrochlorothiazide | 15 | $132 | $9 |
| Tizanidine | 12 | $109 | $9 |
| Diazepam | 22 | $90 | $4 |
| Cyclobenzaprine | 20 | $79 | $4 |
| Cephalexin | 13 | $49 | $4 |
2021: 44 drugs
| Januvia | 16 | $22,751 | $1,422 |
| Eliquis | 14 | $15,740 | $1,124 |
| Wixela Inhub | 15 | $7,253 | $484 |
| Levothyroxine | 114 | $2,894 | $25 |
| Atorvastatin | 85 | $1,963 | $23 |
| Losartan | 63 | $1,202 | $19 |
| Albuterol Sulfate Hfa | 23 | $1,042 | $45 |
| Tamsulosin | 26 | $868 | $33 |
| Amlodipine Besylate | 59 | $739 | $13 |
| Simvastatin | 73 | $676 | $9 |
| Metoprolol | 17 | $658 | $39 |
| Finasteride | 21 | $652 | $31 |
| Dextroamphetamine Sulfate | 12 | $600 | $50 |
| Trazodone | 36 | $583 | $16 |
| Lisinopril | 55 | $544 | $10 |
| Alendronate | 33 | $523 | $16 |
| Valacyclovir | 13 | $506 | $39 |
| Pantoprazole | 21 | $498 | $24 |
| Clopidogrel | 20 | $462 | $23 |
| Omeprazole | 25 | $455 | $18 |
| Escitalopram | 16 | $431 | $27 |
| Hydrocodone-Acetaminophen | 23 | $394 | $17 |
| Allopurinol | 24 | $376 | $16 |
| Gabapentin | 23 | $376 | $16 |
| Triamterene-Hydrochlorothiazid | 18 | $361 | $20 |
| Sertraline | 26 | $348 | $13 |
| Metformin | 31 | $340 | $11 |
| Ondansetron Odt | 11 | $318 | $29 |
| Montelukast | 12 | $291 | $24 |
| Citalopram Hbr | 18 | $288 | $16 |
| Morphine Sulfate Er | 11 | $282 | $26 |
| Oxycodone-Acetaminophen | 22 | $272 | $12 |
| Carvedilol | 12 | $252 | $21 |
| Metformin Hcl Er | 22 | $251 | $11 |
| Tramadol | 19 | $229 | $12 |
| Hydrochlorothiazide | 32 | $199 | $6 |
| Alprazolam | 23 | $190 | $8 |
| Metoprolol | 12 | $160 | $13 |
| Cyclobenzaprine | 17 | $155 | $9 |
| Zolpidem | 14 | $129 | $9 |
| Lorazepam | 18 | $116 | $6 |
| Furosemide | 15 | $83 | $6 |
| Warfarin | 12 | $59 | $5 |
| Diazepam | 14 | $36 | $3 |
2020: 35 drugs
| Wixela Inhub | 11 | $3,506 | $319 |
| Levothyroxine | 86 | $2,031 | $24 |
| Bupropion Xl | 29 | $1,837 | $63 |
| Ventolin Hfa | 19 | $1,578 | $83 |
| Atorvastatin | 73 | $1,409 | $19 |
| Valacyclovir | 32 | $1,256 | $39 |
| Albuterol Sulfate Hfa | 26 | $1,249 | $48 |
| Tamsulosin | 43 | $966 | $22 |
| Simvastatin | 69 | $596 | $9 |
| Omeprazole | 31 | $572 | $18 |
| Losartan | 37 | $564 | $15 |
| Amlodipine Besylate | 57 | $507 | $9 |
| Sertraline | 34 | $492 | $14 |
| Trazodone | 27 | $476 | $18 |
| Alendronate | 33 | $476 | $14 |
| Metoprolol | 16 | $436 | $27 |
| Finasteride | 21 | $435 | $21 |
| Esomeprazole Magnesium | 12 | $433 | $36 |
| Pantoprazole | 34 | $419 | $12 |
| Allopurinol | 22 | $408 | $19 |
| Metformin | 35 | $373 | $11 |
| Hydrocodone-Acetaminophen | 23 | $364 | $16 |
| Gabapentin | 19 | $319 | $17 |
| Lisinopril | 43 | $314 | $7 |
| Fluticasone Propionate | 15 | $292 | $19 |
| Montelukast | 15 | $288 | $19 |
| Clopidogrel | 16 | $271 | $17 |
| Metformin Hcl Er | 25 | $222 | $9 |
| Estradiol | 11 | $123 | $11 |
| Citalopram Hbr | 12 | $105 | $9 |
| Hydrochlorothiazide | 28 | $98 | $4 |
| Oxycodone-Acetaminophen | 11 | $98 | $9 |
| Alprazolam | 13 | $74 | $6 |
| Warfarin | 16 | $53 | $3 |
| Furosemide | 14 | $47 | $3 |
2019: 37 drugs
| Atorvastatin | 73 | $1,491 | $20 |
| Duloxetine | 24 | $1,222 | $51 |
| Ventolin Hfa | 21 | $1,206 | $57 |
| Fluoxetine | 14 | $1,202 | $86 |
| Levothyroxine | 60 | $1,098 | $18 |
| Bupropion Xl | 17 | $1,054 | $62 |
| Tamsulosin | 34 | $793 | $23 |
| Albuterol Sulfate Hfa | 15 | $732 | $49 |
| Simvastatin | 67 | $632 | $9 |
| Azelastine | 13 | $616 | $47 |
| Amlodipine Besylate | 39 | $463 | $12 |
| Lisinopril | 60 | $445 | $7 |
| Carvedilol | 22 | $431 | $20 |
| Losartan | 38 | $431 | $11 |
| Trazodone | 24 | $349 | $15 |
| Pantoprazole | 23 | $332 | $14 |
| Hydrocodone-Acetaminophen | 24 | $332 | $14 |
| Fluticasone Propionate | 17 | $321 | $19 |
| Finasteride | 13 | $319 | $25 |
| Benazepril | 27 | $269 | $10 |
| Sertraline | 25 | $265 | $11 |
| Metformin | 29 | $244 | $8 |
| Escitalopram | 14 | $239 | $17 |
| Gabapentin | 12 | $201 | $17 |
| Montelukast | 20 | $198 | $10 |
| Alendronate | 28 | $180 | $6 |
| Estradiol | 18 | $180 | $10 |
| Clopidogrel | 16 | $156 | $10 |
| Omeprazole | 14 | $144 | $10 |
| Spironolactone | 15 | $134 | $9 |
| Zolpidem | 17 | $113 | $7 |
| Ciprofloxacin | 12 | $99 | $8 |
| Citalopram Hbr | 11 | $92 | $8 |
| Hydrochlorothiazide | 29 | $91 | $3 |
| Metformin Hcl Er | 14 | $90 | $6 |
| Alprazolam | 16 | $51 | $3 |
| Furosemide | 14 | $44 | $3 |
2018: 27 drugs
| Bupropion Xl | 23 | $1,251 | $54 |
| Levothyroxine | 69 | $961 | $14 |
| Ventolin Hfa | 14 | $778 | $56 |
| Proair Hfa | 11 | $743 | $68 |
| Atorvastatin | 24 | $621 | $26 |
| Simvastatin | 75 | $556 | $7 |
| Hydrocodone-Acetaminophen | 28 | $517 | $18 |
| Tamsulosin | 11 | $358 | $33 |
| Trazodone | 27 | $308 | $11 |
| Gabapentin | 22 | $303 | $14 |
| Duloxetine | 13 | $266 | $20 |
| Sertraline | 21 | $256 | $12 |
| Metformin | 26 | $252 | $10 |
| Spironolactone | 13 | $228 | $18 |
| Amlodipine Besylate | 36 | $216 | $6 |
| Quetiapine | 16 | $185 | $12 |
| Losartan | 22 | $151 | $7 |
| Montelukast | 12 | $140 | $12 |
| Alendronate | 13 | $128 | $10 |
| Lisinopril | 17 | $103 | $6 |
| Zolpidem | 15 | $100 | $7 |
| Benazepril | 14 | $97 | $7 |
| Estradiol | 11 | $80 | $7 |
| Furosemide | 22 | $66 | $3 |
| Alprazolam | 16 | $64 | $4 |
| Metformin Hcl Er | 12 | $54 | $4 |
| Hydrochlorothiazide | 13 | $52 | $4 |
2017: 15 drugs
| Levothyroxine | 44 | $608 | $14 |
| Simvastatin | 75 | $573 | $8 |
| Venlafaxine Hcl Er | 12 | $499 | $42 |
| Atorvastatin | 20 | $419 | $21 |
| Alendronate | 31 | $400 | $13 |
| Omeprazole | 25 | $347 | $14 |
| Amlodipine Besylate | 32 | $322 | $10 |
| Metformin | 25 | $198 | $8 |
| Hydrocodone-Acetaminophen | 12 | $133 | $11 |
| Zolpidem | 12 | $129 | $11 |
| Benazepril | 17 | $125 | $7 |
| Azithromycin | 13 | $117 | $9 |
| Losartan-Hydrochlorothiazide | 12 | $111 | $9 |
| Losartan | 17 | $86 | $5 |
| Alprazolam | 13 | $47 | $4 |
2016: 72 drugs
| Lantus Solostar | 19 | $10,708 | $564 |
| Advair Diskus | 17 | $6,826 | $402 |
| Zetia | 21 | $6,695 | $319 |
| Linzess | 16 | $6,347 | $397 |
| Lyrica | 11 | $5,651 | $514 |
| Hydrocodone-Acetaminophen | 118 | $5,478 | $46 |
| Spiriva | 11 | $4,880 | $444 |
| Metformin Hcl Er | 36 | $3,447 | $96 |
| Premarin | 14 | $2,700 | $193 |
| Levothyroxine | 181 | $2,388 | $13 |
| Synthroid | 33 | $1,573 | $48 |
| Atorvastatin | 122 | $1,541 | $13 |
| Omeprazole | 121 | $1,430 | $12 |
| Pravastatin | 56 | $1,095 | $20 |
| Amlodipine Besylate | 128 | $1,090 | $9 |
| Oxycodone-Acetaminophen | 13 | $1,038 | $80 |
| Fenofibrate | 24 | $1,008 | $42 |
| Tamsulosin | 36 | $928 | $26 |
| Zolpidem | 29 | $909 | $31 |
| Metformin | 138 | $908 | $7 |
| Potassium Chloride | 25 | $710 | $28 |
| Lisinopril | 111 | $703 | $6 |
| Losartan | 82 | $668 | $8 |
| Proair Hfa | 12 | $646 | $54 |
| Fluticasone Propionate | 44 | $637 | $14 |
| Simvastatin | 93 | $628 | $7 |
| Levocetirizine Dihydrochloride | 32 | $579 | $18 |
| Hydrochlorothiazide | 61 | $552 | $9 |
| Fenofibrate | 12 | $508 | $42 |
| Bupropion Xl | 18 | $449 | $25 |
| Ropinirole | 25 | $443 | $18 |
| Metoprolol | 23 | $441 | $19 |
| Alendronate | 78 | $428 | $5 |
| Metoprolol | 85 | $418 | $5 |
| Temazepam | 29 | $387 | $13 |
| Sertraline | 53 | $383 | $7 |
| Trazodone | 55 | $374 | $7 |
| Gabapentin | 41 | $374 | $9 |
| Tizanidine | 18 | $370 | $21 |
| Venlafaxine Hcl Er | 31 | $339 | $11 |
| Montelukast | 26 | $332 | $13 |
| Bd Ultra-Fine Pen Needle | 11 | $315 | $29 |
| Fluoxetine | 30 | $306 | $10 |
| Enalapril Maleate | 12 | $288 | $24 |
| Lisinopril-Hydrochlorothiazide | 50 | $282 | $6 |
| Lovastatin | 35 | $279 | $8 |
| Ranitidine | 22 | $264 | $12 |
| Allopurinol | 25 | $262 | $10 |
| Alprazolam | 43 | $247 | $6 |
| Valsartan-Hydrochlorothiazide | 17 | $243 | $14 |
| Losartan-Hydrochlorothiazide | 28 | $240 | $9 |
| Atenolol | 34 | $229 | $7 |
| Meloxicam | 23 | $216 | $9 |
| Glipizide Er | 11 | $213 | $19 |
| Pantoprazole | 25 | $202 | $8 |
| Warfarin | 18 | $194 | $11 |
| Methylprednisolone | 12 | $189 | $16 |
| Glipizide | 27 | $186 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $180 | $16 |
| Azithromycin | 31 | $174 | $6 |
| Citalopram Hbr | 39 | $170 | $4 |
| Clopidogrel | 26 | $169 | $7 |
| Estradiol | 12 | $134 | $11 |
| Tramadol | 20 | $126 | $6 |
| Diazepam | 22 | $117 | $5 |
| Carvedilol | 21 | $114 | $5 |
| Terazosin | 19 | $105 | $6 |
| Finasteride | 12 | $99 | $8 |
| Benazepril | 21 | $83 | $4 |
| Quetiapine | 11 | $64 | $6 |
| Lorazepam | 12 | $57 | $5 |
| Furosemide | 18 | $41 | $2 |
2015: 65 drugs
| Zetia | 21 | $6,524 | $311 |
| Advair Diskus | 17 | $4,617 | $272 |
| Hydrocodone-Acetaminophen | 119 | $4,396 | $37 |
| Levothyroxine | 165 | $2,451 | $15 |
| Morphine Sulfate Er | 16 | $1,925 | $120 |
| Premarin | 11 | $1,876 | $171 |
| Synthroid | 31 | $1,851 | $60 |
| Fenofibrate | 11 | $1,264 | $115 |
| Omeprazole | 104 | $1,201 | $12 |
| Pravastatin | 50 | $1,107 | $22 |
| Atorvastatin | 74 | $1,050 | $14 |
| Proair Hfa | 19 | $989 | $52 |
| Bupropion Xl | 23 | $932 | $41 |
| Gabapentin | 47 | $930 | $20 |
| Fenofibrate | 16 | $869 | $54 |
| Lorazepam | 20 | $791 | $40 |
| Metformin | 123 | $764 | $6 |
| Ventolin Hfa | 14 | $704 | $50 |
| Levocetirizine Dihydrochloride | 45 | $693 | $15 |
| Amlodipine Besylate | 95 | $669 | $7 |
| Fluticasone Propionate | 44 | $632 | $14 |
| Lisinopril | 85 | $598 | $7 |
| Simvastatin | 64 | $522 | $8 |
| Hydrochlorothiazide | 73 | $509 | $7 |
| Losartan | 73 | $494 | $7 |
| Potassium Chloride | 12 | $492 | $41 |
| Tamsulosin | 26 | $488 | $19 |
| Valsartan-Hydrochlorothiazide | 14 | $478 | $34 |
| Fenofibrate | 11 | $465 | $42 |
| Fluoxetine | 28 | $403 | $14 |
| Metoprolol | 17 | $376 | $22 |
| Trazodone | 48 | $362 | $8 |
| Montelukast | 35 | $347 | $10 |
| Triamcinolone Acetonide | 13 | $327 | $25 |
| Tizanidine | 14 | $312 | $22 |
| Sertraline | 37 | $309 | $8 |
| Lovastatin | 36 | $305 | $8 |
| Methylprednisolone | 17 | $296 | $17 |
| Metformin Hcl Er | 36 | $275 | $8 |
| Verapamil Er | 11 | $263 | $24 |
| Metoprolol | 50 | $263 | $5 |
| Lisinopril-Hydrochlorothiazide | 39 | $252 | $6 |
| Temazepam | 30 | $244 | $8 |
| Glipizide Er | 13 | $239 | $18 |
| Warfarin | 16 | $237 | $15 |
| Losartan-Hydrochlorothiazide | 25 | $223 | $9 |
| Alprazolam | 38 | $214 | $6 |
| Clopidogrel | 21 | $200 | $10 |
| Benazepril | 36 | $200 | $6 |
| Alendronate | 23 | $197 | $9 |
| Finasteride | 22 | $187 | $9 |
| Citalopram Hbr | 36 | $183 | $5 |
| Atenolol | 17 | $173 | $10 |
| Ibuprofen | 11 | $169 | $15 |
| Allopurinol | 14 | $160 | $11 |
| Quetiapine | 12 | $151 | $13 |
| Ranitidine | 19 | $123 | $6 |
| Carvedilol | 24 | $107 | $4 |
| Meloxicam | 25 | $104 | $4 |
| Tramadol | 12 | $88 | $7 |
| Terazosin | 12 | $78 | $6 |
| Glipizide | 16 | $75 | $5 |
| Diazepam | 14 | $69 | $5 |
| Zolpidem | 16 | $66 | $4 |
| Methocarbamol | 11 | $58 | $5 |
Money from drug and device companies
$83 in 2025
| 2025 | 3 | 3 | None | $83 |
| 2023 | 4 | 16 | None | $367 |
| 2022 | 3 | 7 | None | $112 |
| 2021 | 12 | 22 | None | $392 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $30 | 1 payment
|
| Astellas Pharma US | Veozah | $28 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $25 | 1 payment
|
See all 3 published payments
| Otsuka America Pharmaceutical | Meals · 2025-10-07 | Rexulti | $30 |
| Astellas Pharma US | Meals · 2025-09-23 | Veozah | $28 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $25 |
See earlier years (2023, 2022, 2021)
2023: $367
| Pfizer | Prevnar 20 | $173 | 9 payments
|
| Abbvie | Ubrelvy | $119 | 4 payments
|
| Amgen | Evenity | $46 | 2 payments
|
| Astellas Pharma US | Veozah | $29 | 1 payment
|
2022: $112
| Pfizer | Prevnar 20 | $77 | 5 payments
|
| Novo Nordisk | Rybelsus | $22 | 1 payment
|
| Lilly USA | Trulicity | $13 | 1 payment
|
2021: $392
| Novo Nordisk | Ozempic | $58 | 3 payments
|
| Amgen | Aimovig | $56 | 3 payments
|
| AbbVie | Viibryd | $54 | 3 payments
|
| Insulet | Omnipod | $53 | 3 payments
|
| Lilly USA | Emgality | $42 | 2 payments
|
| Biogen | Aduhelm | $25 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $20 | 1 payment
|
| Sunovion Pharmaceuticals | Gemtesa | $19 | 2 payments
|
| Sun Pharmaceutical Industries | Kapspargo | $18 | 1 payment
|
| Eisai | Dayvigo | $15 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $12 | 1 payment
|
Professional record
- NPI
- 1811397177
- Licence
- NV APRN001756
- Trained
- University of Nevada School of Medicine, 2014 · 12 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 5070 Ion Dr, Sparks, NV, 89436
- NPI first listed
- 2014-08-23
- NPI last updated
- 2024-11-11
- NPI record certified
- 2024-11-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5070 Ion Dr, Sparks, NV, 89436
This office lists an electronic records connection.